Article Information
History
- September 3, 2021.
Article Versions
- Version 1 (August 23, 2021 - 18:10).
- Version 2 (August 25, 2021 - 04:31).
- Version 3 (August 26, 2021 - 12:25).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anton Barchuk1,6,7,✉,
- Mikhail Cherkashin2,
- Anna Bulina1,
- Natalia Berezina2,
- Tatyana Rakova2,
- Darya Kuplevatskaya2,
- Oksana Stanevich3,4,
- Dmitriy Skougarevskiy1 and
- Artemiy Okhotin5
- 1European University at St. Petersburg, Shpalernaya Ulitsa 1, St. Petersburg, Russia, 191187
- 2Medical Institute named after Berezin Sergey, Esenina Ulitsa 2-3a, St. Petersburg, Russia, 194354
- 3First Pavlov State Medical University of St. Petersburg, Ulitsa L’va Tolstogo 6-8, St. Petersburg, Russia, 197022
- 4Smorodintsev Research Institute of Influenza, Ulitsa Professora Popova 15/17, St. Petersburg, Russia, 197022
- 5Tarusa Hospital, Karla Libknekhta Ulitsa 16, Tarusa, Russia, 249100
- 6Petrov National Research Medical Centre of Oncology, Pesochny, Leningradskaya Ulitsa 68, St. Petersburg, Russia, 197758
- 7Health Sciences, Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, Tampere, Finland, 33520
- ↵✉Correspondence: abarchuk{at}eu.spb.ru
Posted September 03, 2021.
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-Based Case-Control Study in St. Petersburg, Russia
